https://www.selleckchem.com/pr....oducts/cobimetinib-g
Therefore, oral administration does not alter the efficacy and safety profile of fluzoparib. The presence of food decreased the absorption rate and peak exposure time of fluzoparib; however, the AUC did not significantly change compared with the fasted condition. Therefore, oral administration does not alter the efficacy and safety profile of fluzoparib.Background Identification of target organ damage and/or risk-enhancing factors help treatment decisions in hypertensive and hyperlipidaemic patients who reside in bor
Like
Comment
Share
